RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Dose-dense chemotherapy with Docetaxel, Cisplatin, folinic acid and 5-fluorouracil (TCAF DD) in metastatic gastric cancer (MGC): A feasibility study
2006-01-01 Dalla Chiesa, M; Tomasello, G; Buti, S; Negli, F; Buononato, M; Lazzarelli, S; Brighenti, M; Passalacqua, R
Dose-dense chemotherapy with modified TCF regimen (TCF-DD) in metastatic gastric cancer (MGC): A feasibility study
2006-01-01 Dalla Chiesa, M; Tomasello, G; Buti, S; Negri, F; Buononato, M; Lazzarelli, S; Brighenti, M; Donati, G; Cattaneo, M; Passalacqua, R
Dose-dense chemotherapy with modified TCF regimen (TCF-DD) in metastatic gastric cancer (MGC): A feasibility study
2006-01-01 Dalla Chiesa, M; Tomasello, G; Buti, S; Negri, F; Buononato, M; Lazzarelli, S; Donati, G
Drug-drug interactions (DDIs) in elderly patients with metastatic renal cell carcinoma (mRCC) treated with cabozantinib within the multicenter prospective trial ZEBRA/Meet-URO 9
2023-01-01 Mattana, Alvise; Del Re, Marzia; Bimbatti, Davide; Buti, Sebastiano; Claps, Melanie; Di Napoli, Marilena; Fratino, Lucia; Santini, Daniele; Sorarù, Mariella; Grillone, Francesco; Mazzaschi, Giulia; Maruzzo, Marco; Pierantoni, Francesco; Ballestrin, Melissa; De Toni, Chiara; Lai, Eleonora; Dionese, Michele; Zagonel, Vittorina; Basso, Umberto
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens
2022-01-01 Mazzaschi, G; Verze, M; Tognazzi, D; Lorusso, B; Minari, R; Pluchino, M; Trentini, F; Manini, M; Bordi, P; Leonetti, A; Perrone, F; Coriano, M; Casali, M; Toscani, I; Cosenza, A; Ferri, L; Buti, S; Sverzellati, N; Quaini, F; Tiseo, M
Early primary tumor response in metastatic RCC patients treated with immune checkpoint inhibitors-based combinations
2022-01-01 Ciccarese, Chiara; Bimbatti, Davide; Atzori, Francesco; Bonato, Adele; Scagliarini, Sarah; Pellegrini, Ilaria; Bracarda, Sergio; De Giorgi, Ugo; Masini, Cristina; Santoni, Matteo; Massari, Francesco; Buti, Sebastiano; Damassi, Alessandra; Zampiva, Ilaria; Strusi, Alessandro; Sparagna, Ileana; Rebuzzi, Sara Elena; Tortora, Giampaolo; Iacovelli, Roberto
Enzalutamide activity in patients with metastatic castration resistant prostate cancer (mCRPC) previously responding to antiandrogen withdrawal syndrome (AWN): A preliminary report
2014-01-01 Bracarda, S; Procopio, G; Alesini, D; Grillone, F; Massari, F; Zaniboni, A; Mattioli, R; Buti, S; Garanzini, E; Sisani, M; Harnzaj, A; Altavilla, A; De Angelis, V
Enzalutamide activity in patients with metastatic castration resistant prostate cancer (mCRPC) previously responding to antiandrogen withdrawal syndrome (AWS): A preliminary report
2014-01-01 Altavilla, A; Procopio, G; Alesini, D; Grillone, F; Massari, F; Zaniboni, A; Mattioli, R; Buti, S; Garanzini, E; Sisani, M; Hamzaj, A; Marrocolo, F; De Angelis, V; Bracarda, S
Erythrocyte mean corpuscolar volume change during pemetrexed chemotherapy in advanced non small cell lung cancer patients
2012-01-01 Bordi, P; Buti, S; Tiseo, M; Panni, S; Novello, S; Bria, E; Rapetti, S; Pilotto, S; Camisa, R; Ardizzoni, A
Erythrocyte mean corpuscular volume change during pemetrexed treatment in advanced non small cell lung cancer patients
2012-01-01 Buti, S; Bordi, P; Tiseo, M; Panni, S; Novello, S; Bria, E; Rapetti, Sg; Pilotto, S; Camisa, R; Ardizzoni, A
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Dose-dense chemotherapy with Docetaxel, Cisplatin, folinic acid and 5-fluorouracil (TCAF DD) in metastatic gastric cancer (MGC): A feasibility study | 1-gen-2006 | Dalla Chiesa, M; Tomasello, G; Buti, S; Negli, F; Buononato, M; Lazzarelli, S; Brighenti, M; Passalacqua, R | |
Dose-dense chemotherapy with modified TCF regimen (TCF-DD) in metastatic gastric cancer (MGC): A feasibility study | 1-gen-2006 | Dalla Chiesa, M; Tomasello, G; Buti, S; Negri, F; Buononato, M; Lazzarelli, S; Brighenti, M; Donati, G; Cattaneo, M; Passalacqua, R | |
Dose-dense chemotherapy with modified TCF regimen (TCF-DD) in metastatic gastric cancer (MGC): A feasibility study | 1-gen-2006 | Dalla Chiesa, M; Tomasello, G; Buti, S; Negri, F; Buononato, M; Lazzarelli, S; Donati, G | |
Drug-drug interactions (DDIs) in elderly patients with metastatic renal cell carcinoma (mRCC) treated with cabozantinib within the multicenter prospective trial ZEBRA/Meet-URO 9 | 1-gen-2023 | Mattana, Alvise; Del Re, Marzia; Bimbatti, Davide; Buti, Sebastiano; Claps, Melanie; Di Napoli, Marilena; Fratino, Lucia; Santini, Daniele; Sorarù, Mariella; Grillone, Francesco; Mazzaschi, Giulia; Maruzzo, Marco; Pierantoni, Francesco; Ballestrin, Melissa; De Toni, Chiara; Lai, Eleonora; Dionese, Michele; Zagonel, Vittorina; Basso, Umberto | |
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens | 1-gen-2022 | Mazzaschi, G; Verze, M; Tognazzi, D; Lorusso, B; Minari, R; Pluchino, M; Trentini, F; Manini, M; Bordi, P; Leonetti, A; Perrone, F; Coriano, M; Casali, M; Toscani, I; Cosenza, A; Ferri, L; Buti, S; Sverzellati, N; Quaini, F; Tiseo, M | |
Early primary tumor response in metastatic RCC patients treated with immune checkpoint inhibitors-based combinations | 1-gen-2022 | Ciccarese, Chiara; Bimbatti, Davide; Atzori, Francesco; Bonato, Adele; Scagliarini, Sarah; Pellegrini, Ilaria; Bracarda, Sergio; De Giorgi, Ugo; Masini, Cristina; Santoni, Matteo; Massari, Francesco; Buti, Sebastiano; Damassi, Alessandra; Zampiva, Ilaria; Strusi, Alessandro; Sparagna, Ileana; Rebuzzi, Sara Elena; Tortora, Giampaolo; Iacovelli, Roberto | |
Enzalutamide activity in patients with metastatic castration resistant prostate cancer (mCRPC) previously responding to antiandrogen withdrawal syndrome (AWN): A preliminary report | 1-gen-2014 | Bracarda, S; Procopio, G; Alesini, D; Grillone, F; Massari, F; Zaniboni, A; Mattioli, R; Buti, S; Garanzini, E; Sisani, M; Harnzaj, A; Altavilla, A; De Angelis, V | |
Enzalutamide activity in patients with metastatic castration resistant prostate cancer (mCRPC) previously responding to antiandrogen withdrawal syndrome (AWS): A preliminary report | 1-gen-2014 | Altavilla, A; Procopio, G; Alesini, D; Grillone, F; Massari, F; Zaniboni, A; Mattioli, R; Buti, S; Garanzini, E; Sisani, M; Hamzaj, A; Marrocolo, F; De Angelis, V; Bracarda, S | |
Erythrocyte mean corpuscolar volume change during pemetrexed chemotherapy in advanced non small cell lung cancer patients | 1-gen-2012 | Bordi, P; Buti, S; Tiseo, M; Panni, S; Novello, S; Bria, E; Rapetti, S; Pilotto, S; Camisa, R; Ardizzoni, A | |
Erythrocyte mean corpuscular volume change during pemetrexed treatment in advanced non small cell lung cancer patients | 1-gen-2012 | Buti, S; Bordi, P; Tiseo, M; Panni, S; Novello, S; Bria, E; Rapetti, Sg; Pilotto, S; Camisa, R; Ardizzoni, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Articolo su rivista 113
- 1 Articolo su rivista::1.5 Abstra... 113
Data di pubblicazione
- 2020 - 2023 38
- 2010 - 2019 45
- 2004 - 2009 30
Editore
- ASCO pubs 11
- Elsevier 6
- SAGE PUBLICATIONS LTD 5
- ELSEVIER 4
- BioMed Central 2
- International Institute of Antica... 1
- LIPPINCOTT WILLIAMS & WILKINS 1
- SAGE 1
Rivista
- ANNALS OF ONCOLOGY 39
- JOURNAL OF CLINICAL ONCOLOGY 39
- TUMORI 8
- I SUPPLEMENTI DI TUMORI 5
- JOURNAL OF THORACIC ONCOLOGY 4
- JOURNAL OF CLINICAL ONCOLOGY 3
- ANTICANCER RESEARCH 2
- GIORNALE ITALIANO DI NEFROLOGIA 2
- JOURNAL FOR IMMUNOTHERAPY OF CANCER 2
- ANTICANCER RESEARCH 1
Keyword
- Poster presentation at AIOM 2022 1
Lingua
- eng 95
- ita 4
- fre 1
Accesso al fulltext
- no fulltext 110
- open 3